Abstract
Advancements in artificial intelligence (AI) offer promising solutions for enhancing clinical workflows and patient care, potentially revolutionizing healthcare delivery. However, the traditional paradigm of AI integration in healthcare is limited by models that rely on single input modalities during training and require extensive labeled data, failing to capture the multimodal nature of medical practice. Multimodal foundation models, particularly Large Vision Language Models (VLMs), have the potential to overcome these limitations by processing diverse data types and learning from large-scale unlabeled datasets or natural pairs of different modalities, thereby significantly contributing to the development of more robust and versatile AI systems in healthcare. In this review, we establish a unified terminology for multimodal foundation models for medical imaging applications and provide a systematic analysis of papers published between 2012 and 2024. In total, we screened 1,144 papers from medical and AI domains and extracted data from 97 included studies. Our comprehensive effort aggregates the collective knowledge of prior work, evaluates the current state of multimodal AI in healthcare, and delineates both prevailing limitations and potential growth areas. We provide implementation guidelines and actionable recommendations for various stakeholders, including model developers, clinicians, policymakers, and dataset curators.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.